OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
DNA Repair Pathways in Cancer Therapy and Resistance
Lanya Li, Yidi Guan, Xisha Chen, et al.
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 283
Lanya Li, Yidi Guan, Xisha Chen, et al.
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 283
Showing 1-25 of 283 citing articles:
Trends in kinase drug discovery: targets, indications and inhibitor design
Misty M. Attwood, Doriano Fabbro, Aleksandr V. Sokolov, et al.
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 11, pp. 839-861
Closed Access | Times Cited: 578
Misty M. Attwood, Doriano Fabbro, Aleksandr V. Sokolov, et al.
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 11, pp. 839-861
Closed Access | Times Cited: 578
Battling Chemoresistance in Cancer: Root Causes and Strategies to Uproot Them
Alisha Ramos, Samira Sadeghi, Hossein Tabatabaeian
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9451-9451
Open Access | Times Cited: 177
Alisha Ramos, Samira Sadeghi, Hossein Tabatabaeian
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9451-9451
Open Access | Times Cited: 177
Novel nanomedicines to overcome cancer multidrug resistance
Zhenwei Su, Shaowei Dong, Shan‐Chao Zhao, et al.
Drug Resistance Updates (2021) Vol. 58, pp. 100777-100777
Closed Access | Times Cited: 137
Zhenwei Su, Shaowei Dong, Shan‐Chao Zhao, et al.
Drug Resistance Updates (2021) Vol. 58, pp. 100777-100777
Closed Access | Times Cited: 137
Understanding and targeting resistance mechanisms in cancer
Zi‐Ning Lei, Tian Qin, Qiu‐Xu Teng, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 114
Zi‐Ning Lei, Tian Qin, Qiu‐Xu Teng, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 114
DNA Damage Response in Cancer Therapy and Resistance: Challenges and Opportunities
Dana Jurkovičová, Christiana M. Neophytou, Ana Čipak Gašparović, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14672-14672
Open Access | Times Cited: 78
Dana Jurkovičová, Christiana M. Neophytou, Ana Čipak Gašparović, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14672-14672
Open Access | Times Cited: 78
Of the many cellular responses activated by TP53, which ones are critical for tumour suppression?
Annabella Thomas, Gemma L. Kelly, Andreas Strasser
Cell Death and Differentiation (2022) Vol. 29, Iss. 5, pp. 961-971
Open Access | Times Cited: 77
Annabella Thomas, Gemma L. Kelly, Andreas Strasser
Cell Death and Differentiation (2022) Vol. 29, Iss. 5, pp. 961-971
Open Access | Times Cited: 77
Targeted Therapy and Mechanisms of Drug Resistance in Breast Cancer
Briana Kinnel, Santosh Kumar Singh, Gabriela Oprea‐Ilies, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1320-1320
Open Access | Times Cited: 77
Briana Kinnel, Santosh Kumar Singh, Gabriela Oprea‐Ilies, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1320-1320
Open Access | Times Cited: 77
Nuclear-Mitochondrial Interactions
Brittni R. Walker, Carlos T. Moraes
Biomolecules (2022) Vol. 12, Iss. 3, pp. 427-427
Open Access | Times Cited: 74
Brittni R. Walker, Carlos T. Moraes
Biomolecules (2022) Vol. 12, Iss. 3, pp. 427-427
Open Access | Times Cited: 74
DNA Damage and Its Role in Cancer Therapeutics
Jaeyoung Moon, Ichiwa Kitty, Kusuma Renata, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4741-4741
Open Access | Times Cited: 42
Jaeyoung Moon, Ichiwa Kitty, Kusuma Renata, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4741-4741
Open Access | Times Cited: 42
Schiff bases and their metal complexes to target and overcome (multidrug) resistance in cancer
Ana Podolski-Renić, Ana Čipak Gašparović, Andreia Valente, et al.
European Journal of Medicinal Chemistry (2024) Vol. 270, pp. 116363-116363
Closed Access | Times Cited: 23
Ana Podolski-Renić, Ana Čipak Gašparović, Andreia Valente, et al.
European Journal of Medicinal Chemistry (2024) Vol. 270, pp. 116363-116363
Closed Access | Times Cited: 23
Utilizing non-coding RNA-mediated regulation of ATP binding cassette (ABC) transporters to overcome multidrug resistance to cancer chemotherapy
Kenneth K.W. To, Zoufang Huang, Hang Zhang, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101058-101058
Closed Access | Times Cited: 20
Kenneth K.W. To, Zoufang Huang, Hang Zhang, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101058-101058
Closed Access | Times Cited: 20
AXL signaling in cancer: from molecular insights to targeted therapies
Monika Yadav, Anuj K. Sharma, Ketki Patne, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Monika Yadav, Anuj K. Sharma, Ketki Patne, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Unboxing the molecular modalities of mutagens in cancer
Smita Kumari, Sudhanshu Sharma, Dia Advani, et al.
Environmental Science and Pollution Research (2021) Vol. 29, Iss. 41, pp. 62111-62159
Open Access | Times Cited: 73
Smita Kumari, Sudhanshu Sharma, Dia Advani, et al.
Environmental Science and Pollution Research (2021) Vol. 29, Iss. 41, pp. 62111-62159
Open Access | Times Cited: 73
The Impact of the Microbiome on Resistance to Cancer Treatment with Chemotherapeutic Agents and Immunotherapy
Aneta Sevcikova, Nikola Izoldova, Viola Stevurkova, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 1, pp. 488-488
Open Access | Times Cited: 63
Aneta Sevcikova, Nikola Izoldova, Viola Stevurkova, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 1, pp. 488-488
Open Access | Times Cited: 63
The role of extracellular vesicles in the transfer of drug resistance competences to cancer cells
Cristina P. R. Xavier, Dimas Carolina Belisario, Rita Rebelo, et al.
Drug Resistance Updates (2022) Vol. 62, pp. 100833-100833
Open Access | Times Cited: 60
Cristina P. R. Xavier, Dimas Carolina Belisario, Rita Rebelo, et al.
Drug Resistance Updates (2022) Vol. 62, pp. 100833-100833
Open Access | Times Cited: 60
Giulio Donati, Bruno Amati
Molecular Oncology (2022) Vol. 16, Iss. 21, pp. 3828-3854
Open Access | Times Cited: 56
Bioactivity and Development of Small Non-Platinum Metal-Based Chemotherapeutics
Maria Grazia Ferraro, Marialuisa Piccolo, Gabriella Misso, et al.
Pharmaceutics (2022) Vol. 14, Iss. 5, pp. 954-954
Open Access | Times Cited: 55
Maria Grazia Ferraro, Marialuisa Piccolo, Gabriella Misso, et al.
Pharmaceutics (2022) Vol. 14, Iss. 5, pp. 954-954
Open Access | Times Cited: 55
Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer
Priya Yadav, Suresh V. Ambudkar, N. Rajendra Prasad
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 54
Priya Yadav, Suresh V. Ambudkar, N. Rajendra Prasad
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 54
Can Cisplatin Therapy Be Improved? Pathways That Can Be Targeted
Reem Ali, Mustapha Aouida, Abdallah Alhaj Sulaiman, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7241-7241
Open Access | Times Cited: 46
Reem Ali, Mustapha Aouida, Abdallah Alhaj Sulaiman, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7241-7241
Open Access | Times Cited: 46
The Promise of Nanoparticles-Based Radiotherapy in Cancer Treatment
Munima Haque, Md Salman Shakil, Kazi Mustafa Mahmud
Cancers (2023) Vol. 15, Iss. 6, pp. 1892-1892
Open Access | Times Cited: 36
Munima Haque, Md Salman Shakil, Kazi Mustafa Mahmud
Cancers (2023) Vol. 15, Iss. 6, pp. 1892-1892
Open Access | Times Cited: 36
Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance
Divya Ajmeera, Rajanna Ajumeera
Genes & Diseases (2023) Vol. 11, Iss. 1, pp. 148-175
Open Access | Times Cited: 33
Divya Ajmeera, Rajanna Ajumeera
Genes & Diseases (2023) Vol. 11, Iss. 1, pp. 148-175
Open Access | Times Cited: 33
Therapeutic strategies of dual-target small molecules to overcome drug resistance in cancer therapy
Jing Ye, Junhao Wu, Bo Liu
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 3, pp. 188866-188866
Closed Access | Times Cited: 27
Jing Ye, Junhao Wu, Bo Liu
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 3, pp. 188866-188866
Closed Access | Times Cited: 27
Natural-product-based, carrier-free, noncovalent nanoparticles for tumor chemo-photodynamic combination therapy
Zhonglei Wang, Liyan Yang
Pharmacological Research (2024) Vol. 203, pp. 107150-107150
Open Access | Times Cited: 15
Zhonglei Wang, Liyan Yang
Pharmacological Research (2024) Vol. 203, pp. 107150-107150
Open Access | Times Cited: 15
Single-cell multiomics reveals the interplay of clonal evolution and cellular plasticity in hepatoblastoma
Amélie Roehrig, Théo Z. Hirsch, Aurore Pire, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 14
Amélie Roehrig, Théo Z. Hirsch, Aurore Pire, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 14
Cancer Mutations Converge on a Collection of Protein Assemblies to Predict Resistance to Replication Stress
Xiaoyu Zhao, Akshat Singhal, Sungjoon Park, et al.
Cancer Discovery (2024) Vol. 14, Iss. 3, pp. 508-523
Open Access | Times Cited: 13
Xiaoyu Zhao, Akshat Singhal, Sungjoon Park, et al.
Cancer Discovery (2024) Vol. 14, Iss. 3, pp. 508-523
Open Access | Times Cited: 13
